Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV000788828 | SCV000928084 | uncertain significance | not provided | 2018-11-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001856229 | SCV002308808 | uncertain significance | Immunodeficiency 35 | 2022-07-23 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 636873). This variant has not been reported in the literature in individuals affected with TYK2-related conditions. This variant is present in population databases (rs201107041, gnomAD 0.03%). This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 195 of the TYK2 protein (p.Ala195Thr). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Not Available"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |